Evidence map›Paper›PMID 35064089›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

The context of the ribosome binding site in mRNAs defines specificity of action of kasugamycin, an inhibitor of translation initiation.

Yan Zhang, Nikolay A Aleksashin, Dorota Klepacki, Caleb Anderson, Nora Vázquez-Laslop, Carol A Gross, Alexander S Mankin

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Approaches for Studying Context Specificity of Translation Inhibitor Action.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. In Vitro Response of Two Strains ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Increased Motility inInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Paenilamicins from the honey bee pathogenbioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Motif-ation matters.Nature chemical biology · 2023
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yan ZhangDepartment of Microbiology and Immunology, University of California, San Francisco, CA 94158.
Nikolay A AleksashinCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607.ORCID 0000-0002-3403-7587
Dorota KlepackiCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607.
Caleb AndersonCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607.
Nora Vázquez-LaslopCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607.ORCID 0000-0003-2256-693X
Carol A GrossDepartment of Microbiology and Immunology, University of California, San Francisco, CA 94158; Carol.Gross@ucsf.edu shura@uic.edu.
Alexander S MankinCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL 60607; Carol.Gross@ucsf.edu shura@uic.edu.ORCID 0000-0002-3301-827X
University of Illinois Chicago · USQB3 · USUniversity of California, San Francisco · US

Funding

Cellular homeostasis pathways in bacteriaR35GM118061 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, CAROL ANNE · 2016 to 2025
$9.0M
Unraveling context specificity of translation by elucidating the mechanism of action of auxiliary translation factorsR35GM127134 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALEXANDER S MANKIN · 2018 to 2026
$3.2M
NIGMS NIH HHS R35 GM118061NIGMS NIH HHS R35 GM127134
6 · The paper itself

Abstract

Kasugamycin (KSG) is an aminoglycoside antibiotic widely used in agriculture and exhibits considerable medical potential. Previous studies suggested that KSG interferes with translation by blocking binding of canonical messenger RNA (mRNA) and initiator transfer tRNA (tRNA) to the small ribosomal subunit, thereby preventing initiation of protein synthesis. Here, by using genome-wide approaches, we show that KSG can interfere with translation even after the formation of the 70S initiation complex on mRNA, as the extent of KSG-mediated translation inhibition correlates with increased occupancy of start codons by 70S ribosomes. Even at saturating concentrations, KSG does not completely abolish translation, allowing for continuing expression of some

Indexed as

Binding SitesAminoglycosidesCodon, InitiatorMolecular StructureOpen Reading FramesPeptide Chain Initiation, TranslationalProtein BindingProtein BiosynthesisProtein Synthesis InhibitorsRibosomesRNA, MessengerStructure-Activity RelationshipAminoglycosidesCodon, InitiatorkasugamycinProtein Synthesis InhibitorsRNA, Messengerantibioticsribosometranslation initiation

Identifiers

PMID35064089
PMCPMC8794815
OpenAlexW4207063803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.